Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Zuvekas, S. H. Articles by Norquist, G. S. Search for Related Content PubMed Citation Articles by Zuvekas, S. H. Articles by Norquist, G. S. Child/Adolescent Psychiatry Other Somatic Therapy

Recent Trends in Stimulant Medication Use Among U.S. Children

OBJECTIVE: Stimulant medications, such as methylphenidate and amphetamines, are commonly prescribed to treat attention deficit hyperactivity disorder. Stimulant use increased fourfold from 1987 (0.6%) to 1996 (2.4%) among subjects 18-year-old and younger in the U.S. The aim of this study was to determine whether pediatric use of stimulants continued to rise during the period 1997–2002. METHOD: The Medical Expenditure Panel Survey (MEPS) database for the years 1997–2001 was analyzed. The MEPS is a yearly survey of a nationally representative sample of civilian, noninstitutionalized U.S. households, conducted by the U.S. Agency for Health Care Research and Quality. Previously reported estimates from the 1996 MEPS and the 1987 National Medical Expenditure Survey, the predecessor to MEPS, were also replicated to compare recent trends to changes between 1987 and 1996. RESULTS: The prevalence use of stimulants among subjects under 19 years of age was 2.7% (95% C.I. 2.3–3.1) in 1997 and 2.9% (95% C.I. 2.5–3.3) in 2002, with no statistically significant change during these 6 years. Likewise, when pooling data across years and comparing the rate in 1997–1998 (2.8%) with the rate in 2001–2002 (3.0%), no statistically significant changes emerged. Use was highest among 6–12 year olds (4.8% in 2002), as compared with 3.2% among 13–19 year olds and 0.3% among children under 6. An estimated 2.2 million (95% C.I. 1.9–2.6) children received stimulant medication in 2002 as compared to 2.0 million (95% C.I. 1.7–2.3) in 1997. CONCLUSIONS: The steep increase in the utilization of stimulants among children 18 years and younger that occurred over the 1987–1996 period attenuated in the following years through 2002, and has remained stable among very young children.

This article has been cited by other articles:

				M. Gordon Book Review: Diller, L. H. (2006). The Last Normal Child: Essays on the Intersection of Kids, Culture, and Psychiatric Drugs. New York: Praeger J Atten Disord, January 1, 2008; 11(4): 510 - 512. [PDF]

				T. E. Froehlich, B. P. Lanphear, J. N. Epstein, W. J. Barbaresi, S. K. Katusic, and R. S. Kahn Prevalence, Recognition, and Treatment of Attention-Deficit/Hyperactivity Disorder in a National Sample of US Children Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 857 - 864. [Abstract] [Full Text] [PDF]

				L. A. Strohschein Prevalence of methylphenidate use among Canadian children following parental divorce Can. Med. Assoc. J., June 5, 2007; 176(12): 1711 - 1714. [Abstract] [Full Text] [PDF]

				S. N. Visser, C. A. Lesesne, and R. Perou National Estimates and Factors Associated With Medication Treatment for Childhood Attention-Deficit/Hyperactivity Disorder Pediatrics, February 1, 2007; 119(Supplement_1): S99 - S106. [Abstract] [Full Text] [PDF]

				A. Schonwald Pediatric Antipsychotic Prescription Rates Soar AAP Grand Rounds, September 1, 2006; 16(3): 25 - 26. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us